315 related articles for article (PubMed ID: 23825952)
1. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.
Taguchi Y; Mistica AM; Kitamoto T; Schätzl HM
PLoS Pathog; 2013; 9(6):e1003466. PubMed ID: 23825952
[TBL] [Abstract][Full Text] [Related]
2. Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibition.
Taguchi Y; Schätzl HM
Prion; 2013; 7(6):452-6. PubMed ID: 24401595
[TBL] [Abstract][Full Text] [Related]
3. Prion protein self-peptides modulate prion interactions and conversion.
Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
5. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
[TBL] [Abstract][Full Text] [Related]
6. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
Norstrom EM; Mastrianni JA
J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
[TBL] [Abstract][Full Text] [Related]
7. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
Hara H; Sakaguchi S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
[TBL] [Abstract][Full Text] [Related]
8. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
9. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
10. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
Zhang X; Pan YH; Chen Y; Pan C; Ma J; Yuan C; Yu G; Ma J
J Biol Chem; 2021 Nov; 297(5):101344. PubMed ID: 34710372
[TBL] [Abstract][Full Text] [Related]
11. Self-assembly of recombinant prion protein of 106 residues.
Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
[TBL] [Abstract][Full Text] [Related]
12. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
14. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
15. Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells.
Gomes MP; Millen TA; Ferreira PS; e Silva NL; Vieira TC; Almeida MS; Silva JL; Cordeiro Y
J Biol Chem; 2008 Jul; 283(28):19616-25. PubMed ID: 18456654
[TBL] [Abstract][Full Text] [Related]
16. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
17. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
18. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
Norstrom EM; Mastrianni JA
J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
[TBL] [Abstract][Full Text] [Related]
19. Prion infection: seeded fibrillization or more?
Birkmann E; Riesner D
Prion; 2008; 2(2):67-72. PubMed ID: 19098436
[TBL] [Abstract][Full Text] [Related]
20. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
